DANNEX PLC has
announced its merger with Ayrton Drugs Manufacturing Limited and Starwin
Products Limited.
The merger, which
has brought about a new entity–Dannex Ayrton Starwin–has been approved by the
Ghana Stock Exchange.
Shareholders of
the Ayrton Drugs and Starwin Products Limited at their separate extraordinary
general meetings held on December 27, 2018 agreed to the scheme of amalgamation
while in the case of Dannex Plc, its shareholders endorsed the deal on January
30, last year. This was after the High Court of Justice (Commercial Division)
had also given its consent on November 25, 2019.
The register of
members of Ayrton Drugs Manufacturing Limited and Starwin Products Limited will
hence be closed to the general public on Thursday, January 9, with today as the
qualifying date.
Dannex, which
made this known recently, said, “Only shareholders on the register of members
of Ayrton Drugs Manufacturing Limited and Starwin Products Limited at the close
of business on Wednesday, January 8, 2020 will, therefore, be entitled to
receive Dannex Ayrton Starwin Plc shares under the scheme.”
UMB Investment Holdings Limited and UMB Stockbrokers are the financial advisors and sponsoring brokers to the transaction.
A business desk report
